Literature DB >> 3135658

A histogenesis of malignant lymphoma, small cleaved cell of the B cell type and intermediate lymphocytic lymphoma (mantle zone lymphoma). An immuno- and enzymehistochemical study.

M Abe1, N Ono, Y Nozawa, H Hojo, H Wakasa.   

Abstract

We have studied the histogenesis of malignant lymphoma (ML), small cleaved cell of the B-cell type and intermediate lymphocytic lymphoma (mantle zone lymphoma) by comparing immunophenotypes and ALP-activity of neoplastic cells with those of germinal center cells (follicular center cells) and mantle zone (MZ) cells of secondary follicles in non-neoplastic lymphoid tissues. The neoplastic cells in 3 cases of ML, follicular, small cleaved cell and 1 case of ML, small cleaved cell expressed the phenotypes similar to those of germinal center (GC) B lymphocytes (SIgM+, B1+, B2+, CALLA+, SigD-, IL-2R-, Leu-1- and ALP-). The neoplastic cells in 2 cases of ML, follicular, small cleaved cell and 12 cases of ML, diffuse, small cleaved cell displayed the characteristic phenotypes of MZ B lymphocytes (SIgM+, SIgD+, BA-1+, IL-2R+, Leu-1+ and ALP+). The phenotypes of 2 cases of mantle zone lymphoma were closely comparable with those of MZ B lymphocytes. These findings indicate that the histogenesis of ML, small cleaved cell of the B-cell type is heterogeneous and can be divided phenotypically into 2 types (GC B lymphocyte origin and MZ B lymphocyte origin). It is also apparent that intermediate lymphocytic lymphoma (mantle zone lymphoma) is derived from MZ B lymphocytes of secondary follicles.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135658     DOI: 10.1007/bf00718612

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  32 in total

1.  Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas.

Authors:  K Nanba; E S Jaffe; R C Braylan; E J Soban; C W Berard
Journal:  Am J Clin Pathol       Date:  1977-11       Impact factor: 2.493

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  New approaches to the classification of the lymphomata.

Authors:  R J Lukes; R D Collins
Journal:  Br J Cancer Suppl       Date:  1975-03

4.  Selective distribution and quantitation of T-lymphocyte subsets in germinal centers of human tonsils. Definition by use of monoclonal antibodies.

Authors:  L Si; G Roscoe; T L Whiteside
Journal:  Arch Pathol Lab Med       Date:  1983-05       Impact factor: 5.534

5.  Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.

Authors:  J Ritz; L M Nadler; A K Bhan; J Notis-McConarty; J M Pesando; S F Schlossman
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

6.  Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.

Authors:  J Cossman; L M Neckers; S Hsu; D Longo; E S Jaffe
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

7.  Mantle zone lymphoma. Immuno- and enzymehistochemical studies on the cell of origin.

Authors:  J J van den Oord; C de Wolf-Peeters; K A Pulford; D Y Mason; V J Desmet
Journal:  Am J Surg Pathol       Date:  1986-11       Impact factor: 6.394

8.  National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.

Authors: 
Journal:  Cancer       Date:  1982-05-15       Impact factor: 6.860

Review 9.  Immunologic classification of leukemia and lymphoma.

Authors:  K A Foon; R F Todd
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

10.  Stages of B cell differentiation in human lymphoid tissue.

Authors:  A K Bhan; L M Nadler; P Stashenko; R T McCluskey; S F Schlossman
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.